제약-바이오 섹터/섹터
NBI 구성종목 2019년 수익률 및 2020년 구성종목 변경사항
약 장 수
2020. 1. 1. 11:01
반응형
반응형
2019년 장 마지막날이 종료됐습니다. 바이오텍을 대표하는 지수는 Nasdaq Biotech Index (NBI) 입니다. 바이오텍 ETF인 IBB가 NBI를 추종하는 ETF죠. 매년 12월이 되면 NBI의 구성 종목을 변경하고 리발란싱을 합니다. NBI는 weighted로 종목별로 비중을 가중치를 둬서 구성합니다. 바이오텍 투자하실 때 관심종목이 최소한 NBI에 포함되는 종목인지 여부 정도는 알고 투자하시는 것이 좋습니다. 나스닥의 약 500개 정도 되는 바이오텍들 중 약 절반 정도가 NBI에 포함되어 있습니다. 절반 정도에도 포함이 안되는 종목이라면 그야말로 잡주라고 볼 수 있을듯 합니다.
아래 표는 새로 구성된 NBI 구성 종목들의 2019년 수익률입니다. 올해 최고의 수익률을 올린 종목은 Axsome Therapeutics인데 무려 3500% 상승했습니다. 올해 저점 대비로는 5000%입니다. 2019년 나스닥 전체에서 가장 좋은 퍼포먼스를 보인 종목이기도 합니다.
|
심볼
|
이름
|
시총 ($)
|
2019 수익률
|
특이사항
|
|
AXSM
|
Axsome Therapeutics Inc
|
3.8B
|
3565.25%
|
|
|
KOD
|
Kodiak Sciences Inc
|
3.1B
|
913.38%
|
|
|
ARQL
|
ArQule, Inc.
|
2.4B
|
620.58%
|
|
|
ARWR
|
Arrowhead Pharmaceuticals Inc
|
6.3B
|
410.71%
|
|
|
MDCO
|
The Medicines Company
|
6.8B
|
343.78%
|
|
|
ARDX
|
Ardelyx Inc
|
644.0M
|
319.55%
|
|
|
EIDX
|
Eidos Therapeutics Inc
|
2.2B
|
317.08%
|
|
|
EPZM
|
Epizyme Inc
|
2.2B
|
299.35%
|
|
|
ACHN
|
Achillion Pharmaceuticals, Inc.
|
844.8M
|
279.25%
|
|
|
KRTX
|
Karuna Therapeutics Inc
|
2.0B
|
276.32%
|
2019 상장
|
|
XBIT
|
XBiotech Inc
|
766.9M
|
267.52%
|
|
|
ADVM
|
Adverum Biotechnologies Inc
|
744.1M
|
265.71%
|
|
|
RETA
|
Reata Pharmaceuticals Inc
|
6.8B
|
264.40%
|
|
|
CCXI
|
ChemoCentryx Inc
|
2.3B
|
262.51%
|
|
|
ARVN
|
Arvinas Inc
|
1.6B
|
219.77%
|
|
|
IOVA
|
Iovance Biotherapeutics Inc
|
3.5B
|
212.77%
|
|
|
MRTX
|
Mirati Therapeutics Inc
|
5.1B
|
203.77%
|
|
|
ITCI
|
Intra-Cellular Therapies Inc
|
1.9B
|
201.23%
|
|
|
AUPH
|
Aurinia Pharmaceuticals Inc
|
2.8B
|
197.07%
|
|
|
DCPH
|
Deciphera Pharmaceuticals Inc
|
3.2B
|
196.52%
|
|
|
BOLD
|
Audentes Therapeutics Inc
|
2.7B
|
180.68%
|
|
|
CGEN
|
Compugen Ltd.
|
369.3M
|
174.65%
|
|
|
MGTA
|
Magenta Therapeutics Inc
|
591.1M
|
165.96%
|
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
6.6B
|
164.56%
|
|
|
RARX
|
Ra Pharmaceuticals Inc
|
2.2B
|
157.86%
|
|
|
NVCR
|
Novocure Ltd
|
8.3B
|
151.70%
|
|
|
FTSV
|
Forty Seven Inc
|
1.7B
|
150.45%
|
|
|
QURE
|
Uniqure NV
|
3.1B
|
148.65%
|
|
|
APLS
|
Apellis Pharmaceuticals Inc
|
2.0B
|
132.15%
|
|
|
GLPG
|
GALAPAGOS NV/S ADR
|
12.1B
|
125.45%
|
|
|
ASND
|
Ascendis Pharma A/S
|
6.6B
|
122.06%
|
|
|
VCYT
|
Veracyte Inc
|
1.4B
|
121.94%
|
|
|
TPTX
|
Turning Point Therapeutics Inc
|
2.2B
|
115.54%
|
2019 상장
|
|
CRSP
|
Crispr Therapeutics AG
|
3.6B
|
113.20%
|
|
|
DERM
|
Dermira Inc
|
826.5M
|
110.85%
|
|
|
GH
|
Guardant Health Inc
|
7.3B
|
107.87%
|
|
|
MGTX
|
MeiraGTx Holdings PLC
|
732.2M
|
107.68%
|
|
|
DRNA
|
Dicerna Pharmaceuticals Inc
|
1.5B
|
106.08%
|
|
|
KPTI
|
Karyopharm Therapeutics Inc
|
1.2B
|
104.59%
|
|
|
SGEN
|
Seattle Genetics, Inc.
|
19.6B
|
101.66%
|
|
|
PRNB
|
Principia Biopharma Inc
|
1.8B
|
100.00%
|
|
|
CHRS
|
Coherus Biosciences Inc
|
1.3B
|
99.01%
|
|
|
GBT
|
Global Blood Therapeutics Inc
|
4.8B
|
93.64%
|
|
|
NSTG
|
NanoString Technologies Inc
|
994.2M
|
87.59%
|
|
|
HZNP
|
Horizon Therapeutics PLC
|
6.8B
|
85.26%
|
|
|
AXNX
|
Axonics Modulation Technologies Inc
|
940.7M
|
83.39%
|
|
|
FLXN
|
Flexion Therapeutics Inc
|
790.2M
|
82.86%
|
|
|
ALLK
|
Allakos Inc
|
4.6B
|
82.44%
|
|
|
INSM
|
Insmed Incorporated
|
2.1B
|
82.01%
|
|
|
ZLAB
|
Zai Lab Ltd
|
2.8B
|
79.11%
|
|
|
MNTA
|
Momenta Pharmaceuticals, Inc.
|
2.2B
|
78.71%
|
|
|
BDSI
|
BioDelivery Sciences International, Inc.
|
568.2M
|
70.81%
|
|
|
CYTK
|
Cytokinetics, Inc.
|
626.9M
|
67.88%
|
|
|
ADMA
|
ADMA Biologics Inc
|
237.3M
|
67.36%
|
|
|
ARGX
|
argenx SE - ADR
|
6.1B
|
67.09%
|
|
|
CSTL
|
Castle Biosciences Inc
|
586.8M
|
60.61%
|
2019 상장
|
|
TCDA
|
Tricida Inc
|
1.9B
|
60.05%
|
|
|
CHMA
|
Chiasma Inc
|
208.4M
|
59.49%
|
|
|
MEDP
|
Medpace Holdings Inc
|
3.0B
|
58.81%
|
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
12.8B
|
57.96%
|
|
|
AMRN
|
Amarin Corporation plc
|
7.7B
|
57.53%
|
|
|
PRTA
|
Prothena Corporation PLC
|
631.6M
|
53.69%
|
|
|
YMAB
|
Y-mAbs Therapeutics, Inc
|
1.2B
|
53.64%
|
|
|
RCKT
|
Rocket Pharmaceuticals Inc
|
1.2B
|
53.58%
|
|
|
CBPO
|
China Biologic Products Holdings Inc
|
4.5B
|
53.31%
|
|
|
FATE
|
Fate Therapeutics Inc
|
1.5B
|
52.53%
|
|
|
TECH
|
BIO-TECHNE Corp
|
8.4B
|
51.68%
|
|
|
SYNH
|
Syneos Health Inc
|
6.2B
|
51.16%
|
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
9.9B
|
50.53%
|
|
|
MYOK
|
Myokardia Inc
|
3.4B
|
49.18%
|
|
|
EGRX
|
Eagle Pharmaceuticals Inc
|
821.4M
|
49.12%
|
|
|
OPTN
|
OptiNose Inc
|
422.6M
|
48.71%
|
|
|
BPMC
|
Blueprint Medicines Corp
|
3.9B
|
48.60%
|
|
|
VYGR
|
Voyager Therapeutics Inc
|
517.2M
|
48.40%
|
|
|
IMMU
|
Immunomedics, Inc.
|
4.4B
|
48.28%
|
|
|
EIGR
|
Eiger Biopharmaceuticals Inc
|
365.0M
|
46.65%
|
|
|
ZGNX
|
Zogenix, Inc.
|
2.3B
|
42.98%
|
|
|
PTCT
|
PTC Therapeutics, Inc.
|
3.0B
|
39.95%
|
|
|
AIMT
|
Aimmune Therapeutics Inc
|
2.1B
|
39.92%
|
|
|
GTHX
|
G1 Therapeutics Inc
|
993.3M
|
38.02%
|
|
|
INCY
|
Incyte Corporation
|
18.8B
|
37.32%
|
|
|
ANIP
|
ANI Pharmaceuticals Inc Common Stock
|
745.7M
|
36.98%
|
|
|
GERN
|
Geron Corporation
|
271.7M
|
36.00%
|
|
|
GMAB
|
GENMAB A/S/S ADR
|
96.4B
|
35.50%
|
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
56.3B
|
32.13%
|
|
|
EDIT
|
Editas Medicine Inc
|
1.5B
|
30.15%
|
|
|
ESPR
|
Esperion Therapeutics Inc
|
1.6B
|
29.63%
|
|
|
QTRX
|
Quanterix Corp
|
662.0M
|
29.06%
|
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
2.1B
|
28.47%
|
|
|
MRNA
|
Moderna Inc
|
6.5B
|
28.09%
|
|
|
BBIO
|
BridgeBio Pharma Inc
|
4.3B
|
27.22%
|
2019 상장
|
|
GRFS
|
Grifols SA - ADR ADR Class B
|
18.8B
|
26.85%
|
|
|
OMER
|
Omeros Corporation
|
754.7M
|
26.48%
|
|
|
NGM
|
NGM Biopharmaceuticals Inc
|
1.2B
|
25.78%
|
2019 상장
|
|
SYRS
|
Syros Pharmaceuticals Inc
|
293.3M
|
24.06%
|
|
|
CARA
|
Cara Therapeutics Inc
|
752.0M
|
23.92%
|
|
|
AMGN
|
Amgen, Inc.
|
143.2B
|
23.84%
|
|
|
ICPT
|
Intercept Pharmaceuticals Inc
|
4.1B
|
22.95%
|
|
|
PTLA
|
Portola Pharmaceuticals Inc
|
1.9B
|
22.34%
|
|
|
RDUS
|
Radius Health Inc
|
930.8M
|
22.26%
|
|
|
XLRN
|
Acceleron Pharma Inc
|
2.8B
|
21.75%
|
|
|
MNKD
|
MannKind Corporation
|
266.3M
|
21.70%
|
|
|
PGNX
|
Progenics Pharmaceuticals, Inc.
|
439.9M
|
21.19%
|
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
2.6B
|
21.19%
|
|
|
AKRO
|
Akero Therapeutics Inc
|
633.9M
|
21.15%
|
2019 상장
|
|
AVRO
|
Avrobio Inc
|
637.5M
|
20.90%
|
|
|
PRAH
|
PRA Health Sciences Inc
|
7.0B
|
20.87%
|
|
|
JAZZ
|
Jazz Pharmaceuticals PLC
|
8.4B
|
20.43%
|
|
|
ATNX
|
Athenex Inc
|
1.2B
|
20.33%
|
|
|
COLL
|
Collegium Pharmaceutical Inc
|
690.0M
|
19.86%
|
|
|
SRPT
|
Sarepta Therapeutics Inc
|
9.6B
|
18.24%
|
|
|
BGNE
|
Beigene Ltd
|
130.1B
|
18.18%
|
|
|
ARNA
|
Arena Pharmaceuticals, Inc.
|
2.3B
|
16.61%
|
|
|
PRVL
|
Prevail Therapeutics Inc
|
539.8M
|
16.40%
|
2019 상장
|
|
SNY
|
Sanofi SA
|
62.9B
|
15.64%
|
|
|
AKBA
|
Akebia Therapeutics Inc
|
751.7M
|
14.29%
|
|
|
PDLI
|
PDL BioPharma Inc
|
370.5M
|
12.07%
|
|
|
IONS
|
Ionis Pharmaceuticals Inc
|
8.5B
|
11.75%
|
|
|
ALXN
|
Alexion Pharmaceuticals, Inc.
|
23.9B
|
11.08%
|
|
|
STOK
|
Stoke Therapeutics Inc
|
926.9M
|
10.75%
|
2019 상장
|
|
ILMN
|
Illumina, Inc.
|
48.8B
|
10.61%
|
|
|
HCM
|
HUTCHISON CHINA/S ADR
|
2.5B
|
8.58%
|
|
|
TBIO
|
Translate Bio Inc
|
488.6M
|
8.53%
|
|
|
NTLA
|
Intellia Therapeutics Inc
|
717.1M
|
7.47%
|
|
|
GWPH
|
GW Pharmaceuticals PLC- ADR
|
38.5B
|
7.36%
|
|
|
PETQ
|
PetIQ Inc
|
708.2M
|
6.73%
|
|
|
IMGN
|
ImmunoGen, Inc.
|
764.2M
|
6.46%
|
|
|
PCRX
|
Pacira Biosciences Inc
|
1.9B
|
5.30%
|
|
|
PTGX
|
Protagonist Therapeutics Inc
|
191.8M
|
4.75%
|
|
|
GILD
|
Gilead Sciences, Inc.
|
82.2B
|
3.88%
|
|
|
AGIO
|
Agios Pharmaceuticals Inc
|
3.2B
|
3.56%
|
|
|
CLLS
|
Cellectis SA
|
726.7M
|
2.82%
|
|
|
EOLS
|
Evolus Inc
|
406.8M
|
2.27%
|
|
|
AGLE
|
Aeglea Bio Therapeutics Inc
|
221.6M
|
2.00%
|
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
2.5B
|
1.67%
|
|
|
TBPH
|
Theravance Biopharma Inc
|
1.5B
|
1.17%
|
|
|
REGN
|
Regeneron Pharmaceuticals Inc
|
40.5B
|
0.53%
|
|
|
LMNX
|
Luminex Corporation
|
1.0B
|
0.22%
|
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
15.2B
|
-0.70%
|
|
|
BIIB
|
Biogen Inc
|
53.5B
|
-1.39%
|
|
|
RARE
|
Ultragenyx Pharmaceutical Inc
|
2.5B
|
-1.77%
|
|
|
KURA
|
Kura Oncology Inc
|
623.1M
|
-2.07%
|
|
|
RGNX
|
Regenxbio Inc
|
1.5B
|
-2.34%
|
|
|
AMPH
|
Amphastar Pharmaceuticals Inc
|
905.4M
|
-3.07%
|
|
|
ALLO
|
Allogene Therapeutics Inc
|
3.2B
|
-3.53%
|
|
|
ALEC
|
Alector Inc
|
1.2B
|
-4.28%
|
2019 상장
|
|
XNCR
|
Xencor Inc
|
2.0B
|
-4.89%
|
|
|
MYGN
|
Myriad Genetics, Inc.
|
2.0B
|
-6.33%
|
|
|
CRBP
|
Corbus Pharmaceuticals Holdings Inc
|
353.1M
|
-6.51%
|
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
358.7M
|
-6.96%
|
|
|
FOMX
|
Foamix Pharmaceuticals Ltd
|
204.0M
|
-7.24%
|
|
|
FGEN
|
FibroGen Inc
|
3.7B
|
-7.32%
|
|
|
FIXX
|
Homology Medicines Inc
|
911.5M
|
-7.42%
|
|
|
AMRS
|
Amyris Inc
|
326.0M
|
-7.49%
|
|
|
TWST
|
Twist Bioscience Corp
|
695.5M
|
-9.05%
|
|
|
ASMB
|
Assembly Biosciences Inc
|
658.0M
|
-9.55%
|
|
|
OSMT
|
Osmotica Pharmaceuticals PLC
|
362.8M
|
-9.81%
|
|
|
ACIU
|
AC Immune SA
|
575.6M
|
-9.84%
|
|
|
EXEL
|
Exelixis, Inc.
|
5.4B
|
-10.42%
|
|
|
BLUE
|
bluebird bio Inc
|
4.9B
|
-11.54%
|
|
|
AFMD
|
Affimed NV
|
208.9M
|
-11.90%
|
|
|
ORTX
|
Orchard Therapeutics PLC - ADR
|
1.3B
|
-12.59%
|
|
|
ENTA
|
Enanta Pharmaceuticals Inc
|
1.2B
|
-12.78%
|
|
|
GOSS
|
Gossamer Bio Inc
|
1.0B
|
-12.88%
|
2019 상장
|
|
BCEL
|
Atreca Inc
|
340.8M
|
-14.29%
|
2019 상장
|
|
MGNX
|
MacroGenics Inc
|
532.7M
|
-14.33%
|
|
|
RYTM
|
Rhythm Pharmaceuticals Inc
|
1.0B
|
-14.58%
|
|
|
DNLI
|
Denali Therapeutics Inc
|
1.7B
|
-15.68%
|
|
|
XON
|
Intrexon Corp
|
891.5M
|
-16.21%
|
|
|
CERS
|
Cerus Corporation
|
592.2M
|
-16.77%
|
|
|
INO
|
Inovio Pharmaceuticals Inc
|
330.0M
|
-17.50%
|
|
|
EYPT
|
Eyepoint Pharmaceuticals Inc
|
167.6M
|
-17.99%
|
|
|
INVA
|
Innoviva Inc
|
1.4B
|
-18.85%
|
|
|
UTHR
|
United Therapeutics Corporation
|
3.9B
|
-19.12%
|
|
|
RVNC
|
Revance Therapeutics Inc
|
837.6M
|
-19.37%
|
|
|
AMAG
|
AMAG Pharmaceuticals, Inc.
|
412.8M
|
-19.88%
|
|
|
DTIL
|
Precision BioSciences Inc
|
705.4M
|
-20.36%
|
2019 상장
|
|
URGN
|
Urogen Pharma Ltd
|
700.1M
|
-22.50%
|
|
|
LGND
|
Ligand Pharmaceuticals Inc.
|
1.8B
|
-23.15%
|
|
|
MCRB
|
Seres Therapeutics Inc
|
241.5M
|
-23.67%
|
|
|
SAGE
|
SAGE Therapeutics Inc
|
3.7B
|
-24.64%
|
|
|
ADPT
|
Adaptive Biotechnologies Corp
|
3.7B
|
-25.76%
|
2019 상장
|
|
MYL
|
Mylan NV
|
10.4B
|
-26.64%
|
|
|
SGMO
|
Sangamo Therapeutics Inc
|
970.4M
|
-27.09%
|
|
|
SUPN
|
Supernus Pharmaceuticals Inc
|
1.2B
|
-28.60%
|
|
|
PACB
|
Pacific Biosciences of California
|
786.6M
|
-30.54%
|
|
|
ALKS
|
Alkermes Plc
|
3.2B
|
-30.87%
|
|
|
AERI
|
Aerie Pharmaceuticals Inc
|
1.1B
|
-33.05%
|
|
|
NKTR
|
Nektar Therapeutics
|
3.8B
|
-34.32%
|
|
|
ENDP
|
Endo International PLC
|
1.1B
|
-35.75%
|
|
|
TXMD
|
TherapeuticsMD Inc
|
656.2M
|
-36.48%
|
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
875.3M
|
-37.20%
|
|
|
PRQR
|
ProQR Therapeutics NV
|
489.2M
|
-37.20%
|
|
|
RTRX
|
Retrophin Inc
|
610.0M
|
-37.25%
|
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
441.0M
|
-37.50%
|
|
|
SIGA
|
SIGA Technologies, Inc.
|
386.7M
|
-39.62%
|
|
|
RUBY
|
Rubius Therapeutics Inc
|
758.1M
|
-40.92%
|
|
|
GRTS
|
Gritstone Oncology Inc
|
321.2M
|
-41.94%
|
|
|
SRRK
|
Scholar Rock Holding Corp
|
391.2M
|
-42.62%
|
|
|
AKCA
|
Akcea Therapeutics Inc
|
1.6B
|
-43.80%
|
|
|
GLYC
|
GlycoMimetics Inc
|
229.4M
|
-44.14%
|
|
|
CTMX
|
CytomX Therapeutics Inc
|
377.6M
|
-44.97%
|
|
|
OPK
|
Opko Health Inc.
|
978.4M
|
-51.16%
|
|
|
ATRA
|
Atara Biotherapeutics Inc
|
891.9M
|
-52.59%
|
|
|
UBX
|
Unity Biotechnology Inc
|
331.2M
|
-55.66%
|
|
|
AKRX
|
Akorn, Inc.
|
189.2M
|
-55.75%
|
|
|
PBYI
|
Puma Biotechnology Inc
|
340.9M
|
-57.00%
|
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
531.5M
|
-57.25%
|
|
|
SPPI
|
Spectrum Pharmaceuticals, Inc.
|
411.2M
|
-58.40%
|
|
|
XERS
|
Xeris Pharmaceuticals Inc
|
190.3M
|
-58.53%
|
|
|
AUTL
|
Autolus Therapeutics Ltd - ADR
|
593.8M
|
-59.81%
|
|
|
PSNL
|
Personalis Inc
|
340.5M
|
-61.74%
|
2019 상장
|
|
ANAB
|
AnaptysBio Inc
|
440.9M
|
-74.53%
|
|
|
CBAY
|
CymaBay Therapeutics Inc
|
134.7M
|
-75.10%
|
|
|
WVE
|
Wave Life Sciences Ltd
|
274.8M
|
-80.92%
|
|
|
TORC
|
resTORbio, Inc.
|
54.3M
|
-82.71%
|
|
|
SLDB
|
Solid Biosciences Inc
|
204.6M
|
-83.40%
|
|
아래는 위 리스트 중 2019년 12월에 신규 편입된 종목들입니다.
|
ADPT
|
Adaptive Biotechnologies Corp
|
3.7B
|
|
ADMA
|
ADMA Biologics Inc
|
237.3M
|
|
AFMD
|
Affimed NV
|
208.9M
|
|
AKRO
|
Akero Therapeutics Inc
|
633.9M
|
|
ALEC
|
Alector Inc
|
1.2B
|
|
ALLO
|
Allogene Therapeutics Inc
|
3.2B
|
|
ARDX
|
Ardelyx Inc
|
644.0M
|
|
ARVN
|
Arvinas Inc
|
1.6B
|
|
ASMB
|
Assembly Biosciences Inc
|
658.0M
|
|
BCEL
|
Atreca Inc
|
340.8M
|
|
AXNX
|
Axonics Modulation Technologies Inc
|
940.7M
|
|
AXSM
|
Axsome Therapeutics Inc
|
3.8B
|
|
BDSI
|
BioDelivery Sciences International, Inc.
|
568.2M
|
|
BBIO
|
BridgeBio Pharma Inc
|
4.3B
|
|
CSTL
|
Castle Biosciences Inc
|
586.8M
|
|
CHMA
|
Chiasma Inc
|
208.4M
|
|
CGEN
|
Compugen Ltd.
|
369.3M
|
|
GMAB
|
GENMAB A/S/S ADR
|
96.4B
|
|
GOSS
|
Gossamer Bio Inc
|
1.0B
|
|
GRTS
|
Gritstone Oncology Inc
|
321.2M
|
|
GH
|
Guardant Health Inc
|
7.3B
|
|
KRTX
|
Karuna Therapeutics Inc
|
2.0B
|
|
KOD
|
Kodiak Sciences Inc
|
3.1B
|
|
MGTX
|
MeiraGTx Holdings PLC
|
732.2M
|
|
MRNA
|
Moderna Inc
|
6.5B
|
|
NGM
|
NGM Biopharmaceuticals Inc
|
1.2B
|
|
ORTX
|
Orchard Therapeutics PLC - ADR
|
1.3B
|
|
OSMT
|
Osmotica Pharmaceuticals PLC
|
362.8M
|
|
PSNL
|
Personalis Inc
|
340.5M
|
|
DTIL
|
Precision BioSciences Inc
|
705.4M
|
|
PRVL
|
Prevail Therapeutics Inc
|
539.8M
|
|
PRNB
|
Principia Biopharma Inc
|
1.8B
|
|
PTGX
|
Protagonist Therapeutics Inc
|
191.8M
|
|
SNY
|
Sanofi SA
|
62.9B
|
|
SRRK
|
Scholar Rock Holding Corp
|
391.2M
|
|
STOK
|
Stoke Therapeutics Inc
|
926.9M
|
|
TPTX
|
Turning Point Therapeutics Inc
|
2.2B
|
|
TWST
|
Twist Bioscience Corp
|
695.5M
|
|
XBIT
|
XBiotech Inc
|
766.9M
|
|
YMAB
|
Y-mAbs Therapeutics, Inc
|
1.2B
|
아래는 2019년 12월에 NBI에서 탈락한 종목들입니다. 이중에는 인수합병으로 상장폐지된 종목도 있고, 파산한 종목도 있고, 주가가 많이 하락해서 시총이 작아진 종목들도 있습니다. 개중에는 주가가 괜챦았는데 리스트에서 빠진 종목들도 몇개 보이네요.
|
심볼
|
이름
|
시총 ($)
|
2019 수익률
|
특이사항
|
|
ABUS
|
Arbutus Biopharma Corp
|
158.0M
|
-27.42%
|
|
|
ACOR
|
Acorda Therapeutics Inc
|
98.0M
|
-86.91%
|
|
|
ACRS
|
Aclaris Therapeutics Inc
|
78.2M
|
-74.42%
|
|
|
ACRX
|
AcelRx Pharmaceuticals Inc
|
167.9M
|
-8.66%
|
|
|
ADAP
|
Adaptimmune Therapeutics PLC - ADR
|
754.0M
|
-79.13%
|
|
|
ADMS
|
Adamas Pharmaceuticals Inc
|
105.6M
|
-55.62%
|
|
|
ADRO
|
Aduro BioTech Inc
|
95.0M
|
-55.30%
|
|
|
ALDR
|
Delta Drone SA
|
10.2M
|
-94.57%
|
|
|
APTX
|
Aptinyx Inc
|
115.2M
|
-79.32%
|
|
|
AQST
|
Aquestive Therapeutics Inc
|
186.5M
|
-7.62%
|
|
|
ARRY
|
Array Pharmaceuticals
|
인수합병
|
||
|
ASRT
|
Assertio Therapeutics Inc
|
100.9M
|
-65.37%
|
|
|
AXGT
|
Axovant Sciences Ltd
|
116.7M
|
-35.76%
|
|
|
CELG
|
CELGENE ORD
|
77.0B
|
인수합병
|
|
|
CLVS
|
Clovis Oncology Inc
|
571.4M
|
-41.93%
|
|
|
CLXT
|
Calyxt Inc
|
231.0M
|
-32.34%
|
|
|
CNCE
|
Concert Pharmaceuticals Inc
|
219.9M
|
-26.45%
|
|
|
CORI
|
Corium International, Inc.
|
인수합병
|
||
|
CRNX
|
Crinetics Pharmaceuticals Inc
|
607.7M
|
-16.34%
|
|
|
DBVT
|
DBV TECHNOLOGIE/S ADR
|
923.2M
|
66.67%
|
|
|
DOVA
|
Dova Pharmaceuticals, Inc
|
인수합병
|
||
|
ECYT
|
Endocyte, Inc
|
인수합병
|
||
|
ELOX
|
Eloxx Pharmaceuticals Inc
|
294.2M
|
-38.72%
|
|
|
FPRX
|
Five Prime Therapeutics Inc
|
167.0M
|
-50.65%
|
|
|
GHDX
|
Genomic Health, Inc
|
인수합병
|
||
|
INSY
|
INSYS Therapeutics, Inc
|
파산
|
||
|
KALA
|
Kala Pharmaceuticals Inc
|
127.5M
|
-24.54%
|
|
|
KNSA
|
Kiniksa Pharmaceuticals Ltd
|
607.0M
|
-60.63%
|
|
|
LOXO
|
LOXO Oncology
|
인수합병
|
||
|
MNOV
|
MediciNova, Inc.
|
295.5M
|
-17.50%
|
|
|
MRSN
|
Mersana Therapeutics Inc
|
274.4M
|
40.44%
|
|
|
NERV
|
Minerva Neurosciences Inc
|
277.5M
|
5.49%
|
|
|
NVAX
|
Novavax, Inc.
|
105.8M
|
-89.18%
|
|
|
OCUL
|
Ocular Therapeutix Inc
|
189.9M
|
-0.75%
|
|
|
ONCE
|
Spark Therapeutix Inc
|
인수합병
|
||
|
PETX
|
Aratana Therapeutics Inc
|
인수합병
|
||
|
PRTK
|
Paratek Pharmaceuticals Inc
|
134.2M
|
-21.44%
|
|
|
PTI
|
Proteostasis Therapeutics Inc
|
116.6M
|
-29.63%
|
|
|
REPL
|
Replimune Group Inc
|
512.1M
|
43.50%
|
|
|
SBBP
|
Strongbridge Biopharma plc
|
113.3M
|
-53.35%
|
|
|
STIM
|
Neuronetics Inc
|
83.7M
|
-76.80%
|
|
|
SURF
|
Surface Oncology Inc
|
52.4M
|
-55.66%
|
|
|
SVRA
|
Savara Inc
|
184.6M
|
-40.82%
|
|
|
SYBX
|
Synlogic Inc
|
83.3M
|
-63.20%
|
|
|
TOCA
|
Tocagen Inc
|
12.7M
|
-93.54%
|
|
|
TSRO
|
Tesaro Inc
|
인수합병
|
||
|
UMRX
|
Unum Therapeutics Inc
|
22.1M
|
-83.64%
|
|
|
VSTM
|
Verastem Inc
|
99.6M
|
-60.12%
|
|
|
XENE
|
Xenon Pharmaceuticals Inc
|
339.1M
|
107.77%
|
|
|
ZFGN
|
Zafgen Inc
|
41.5M
|
-77.58%
|
반응형